Royalty Pharma
(RPRX) โ
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
26.10
1.40%
After-hours Jan 06, 2025, 05:05 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Cash & Equivalents | 477.01M | 1.71B | 1.54B | 1.01B | 283.68M | 1.92B | 1.38B | 1.67B | 1.72B |
Short-Term Investments | 18.30M | 717.04M | 1.26B | 983.00M | 509.53M | 461.82M | n/a | n/a | n/a |
Long-Term Investments | 1.01B | 14.23B | 14.63B | 13.27B | 11.48B | 8.67B | n/a | n/a | n/a |
Other Long-Term Assets | 14.09B | 15.13M | 4.14M | 28.60M | 87.95M | 19.11M | n/a | n/a | 822.28M |
Receivables | 775.09M | 727.92M | 682.66M | 626.36M | 491.33M | 660.45M | n/a | n/a | n/a |
Inventory | n/a | 1.00 | 1.00 | 657.14M | n/a | 19.20M | n/a | n/a | n/a |
Other Current Assets | 3.80M | 90.52M | 6.63M | 8.60M | 92.00K | -14.50M | 1.57B | 1.33B | 1.32B |
Total Current Assets | 1.27B | 2.55B | 2.88B | 2.70B | 832.07M | 2.61B | 2.95B | 3.00B | 3.04B |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 1.78M | 14.50M | 5.67M | 28.67M | 51.72M | 75.65M | n/a | n/a | 6.95B |
Total Long-Term Assets | 15.11B | 14.26B | 14.64B | 13.32B | 11.62B | 8.76B | 8.43B | 7.48B | 7.77B |
Total Assets | 16.38B | 16.81B | 17.52B | 21.10B | 12.45B | 11.37B | 11.37B | 10.48B | 10.82B |
Account Payables | 15.16M | 7.91M | 5.62M | 10.78M | 11.18M | 4.48M | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | 31.04M | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 997.51M | n/a | n/a | 281.98M | 281.44M | 280.93M | 172.68M | 184.38M |
Other Current Liabilities | 146.21M | 161.37M | 165.63M | 297.11M | 40.26M | 294.26M | 102.48M | 124.63M | 130.01M |
Total Current Liabilities | 161.38M | 1.17B | 171.25M | 307.89M | 333.42M | 580.17M | 383.41M | 297.32M | 314.39M |
Long-Term Debt | 6.14B | 6.12B | 7.10B | 5.82B | 5.96B | 6.24B | 6.52B | 5.72B | 5.80B |
Other Long-Term Liabilities | 900.00K | 2.50M | n/a | n/a | 18.90M | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 6.14B | 6.12B | 7.10B | 5.82B | 5.98B | 6.24B | 6.52B | 5.72B | 5.80B |
Total Liabilities | 6.30B | 7.29B | 7.27B | 6.12B | 6.31B | 6.82B | 6.90B | 6.02B | 6.12B |
Total Debt | 6.14B | 7.12B | 7.10B | 5.82B | 6.24B | 6.52B | 6.80B | 5.90B | 5.99B |
Common Stock | 45.00K | 107.00K | 106.00K | 102.00K | 3.28B | 3.28B | n/a | n/a | n/a |
Retained Earnings | 2.52B | 1.96B | 2.26B | 1.92B | 2.83B | 1.22B | n/a | n/a | n/a |
Comprehensive Income | n/a | 63.00K | 16.49M | 34.40M | 2.09M | -10.26M | n/a | n/a | n/a |
Shareholders Equity | 6.53B | 5.63B | 5.78B | 9.90B | 6.11B | 4.49B | 4.46B | 4.45B | 4.68B |
Total Investments | 1.03B | 533.94M | 15.89B | 14.25B | 11.99B | 605.42M | n/a | n/a | n/a |